Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-275659
Filing Date
2025-11-12
Accepted
2025-11-12 06:08:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d89411d424b5.htm 424B5 514098
2 GRAPHIC g89411g51v03.jpg GRAPHIC 24805
3 GRAPHIC g89411g65s86.jpg GRAPHIC 39984
4 GRAPHIC g89411g90j12.jpg GRAPHIC 38941
  Complete submission text file 0001193125-25-275659.txt   655585
Mailing Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 811591163 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285969 | Film No.: 251468289
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)